DE vs SPRY · P/E 25, rev $45.68B vs rev $89.1M
Deere & Company (DE) versus ARS Pharmaceuticals, Inc (SPRY) — a side-by-side from cached financials, not a winner call.
Deere & Company (DE) is a farm & heavy construction machinery company listed on US. It is led by John May.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Latest reported DE revenue for 2025-11-02 was $45.68B. Net income was $5.03B. Revenue was down 11.7% from 2024-10-27 to 2025-11-02. DE currently screens at market cap $137.72B and trailing P/E 24.6.
Latest reported SPRY revenue for 2024-12-31 was $89.1M. Net income was $8.0M. Revenue was up 297063.3% from 2023-12-31 to 2024-12-31. SPRY currently screens at market cap $983.1M.
DE currently screens at market cap $137.72B and trailing P/E 24.6. SPRY currently screens at market cap $983.1M.
Not investment advice. Open the DE and SPRY stock pages for the full models.
Not investment advice.